The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis-Reference-Cited by-同舟云学术

The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis

Published:2014-10-06 Issue:12 Volume:69 Page:1689-1695
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Devillier P.¹²,Chassany O.³⁴,Vicaut E.⁵,de Beaumont O.⁶,Robin B.⁶,Dreyfus J. F.²,Bousquet P. J.⁷

Affiliation:

1. UPRES EA 220; Hôpital Foch; Université Versailles Saint-Quentin; Suresnes France

2. Délégation à la Recherche Clinique et à l'Innovation; Unité de Méthodologie; Hôpital Foch; Suresnes France

3. Patient-Reported Outcomes Unit; EA REMES; Université Paris-Diderot; Sorbonne Paris Cité; Paris France

4. AP-HP; Département de la Recherche Clinique et du Développement; Hôpital Saint-Louis; Paris France

5. Unité de Recherche Clinique; Hôpital Fernand Vidal; Paris France

6. Stallergenes SA; Antony France

7. Centre Hospitalier Régional Universitaire de Montpellier; Montpellier France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Quality of life in allergic rhinitis and asthma. A population-based study of young adults;Leynaert;Am J Respir Crit Care Med,2000

2. Measuring health-related quality of life in rhinitis;Juniper;J Allergy Clin Immunol,1997

3. Allergic rhinitis and its impact on asthma;Bousquet;J Allergy Clin Immunol,2001

4. EMA European Medicines Agency. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases 2008

5. Interpreting patient-reported outcome results: US FDA guidance and emerging methods;McLeod;Expert Rev Pharmacoecon Outcomes Res,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhinoconjunctivitis severity induced by cat exposure influences early and late asthmatic responses: Evidence from an environmental exposure chamber;Clinical & Experimental Allergy;2024-04-25

2. What Evidence-Based Medicine (EBM) doesn't say about allergen-specific immunotherapy (AIT);Translational Medicine @ UniSa;2023-09-26

3. The minimal clinically important difference of app‐based electronic patient‐reported outcomes for hay fever;Clinical and Translational Allergy;2023-05

4. Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double‐blind placebo‐controlled clinical trial;Clinical & Experimental Allergy;2023-04-04

5. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06